{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T15:24:35Z","timestamp":1779117875971,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T00:00:00Z","timestamp":1433376000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s00431-015-2572-y","type":"journal-article","created":{"date-parts":[[2015,6,3]],"date-time":"2015-06-03T23:16:20Z","timestamp":1433373380000},"page":"1579-1584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":181,"title":["Sirolimus for the treatment of children with various complicated vascular anomalies"],"prefix":"10.1007","volume":"174","author":[{"given":"Herwig","family":"Lackner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Karastaneva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Schwinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Benesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Sovinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Sperl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Lanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emir","family":"Haxhija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich","family":"Reiterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erich","family":"Sorantin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian E.","family":"Urban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,4]]},"reference":[{"key":"2572_CR1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.pcl.2008.01.007","volume":"55","author":"DM Adams","year":"2008","unstructured":"Adams DM, Wentzel MS (2008) The role of the hematologist\/oncologist in the care of patients with vascular anomalies. Pediatr Clin N Am 55:339\u2013355","journal-title":"Pediatr Clin N Am"},{"key":"2572_CR2","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/pbc.22766","volume":"55","author":"J Blatt","year":"2010","unstructured":"Blatt J, Stavas J, Moats-Staats B et al (2010) Treatment of childhood kaposiform hemangioendothelioma with sirolimus. Pediatr Blood Cancer 55:1396\u20131398","journal-title":"Pediatr Blood Cancer"},{"key":"2572_CR3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/pbc.25365","volume":"62","author":"F Blei","year":"2015","unstructured":"Blei F (2015) Kaposiform hemangioendothelioma: therapeutic efficacy for an enigmatic diagnosis. Pediatr Blood Cancer 62:551\u2013552","journal-title":"Pediatr Blood Cancer"},{"key":"2572_CR4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-0032-1329932","volume":"28","author":"F Blei","year":"2012","unstructured":"Blei F (2012) Medical management of vascular anomalies. Facial Plast Surg 28:575\u2013583","journal-title":"Facial Plast Surg"},{"key":"2572_CR5","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199205283262203","volume":"326","author":"RA Ezekowitz","year":"1992","unstructured":"Ezekowitz RA, Mulliken JB, Folkman J (1992) Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 326:1456\u20131463","journal-title":"N Engl J Med"},{"key":"2572_CR6","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/MPH.0b013e3181e001a9","volume":"32","author":"F Fahrtash","year":"2010","unstructured":"Fahrtash F, McCahon E, Arbuckle S (2010) Successful treatment of kaposiform hemangioendothelioma and tufted angioma with vincristine. J Pediatr Hematol Oncol 32:506\u2013510","journal-title":"J Pediatr Hematol Oncol"},{"key":"2572_CR7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1399-3046.2006.00515.x","volume":"10","author":"JC Falger","year":"2006","unstructured":"Falger JC, Mueller T, Arbeiter K et al (2006) Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy. Pediatr Transplant 10:565\u2013569","journal-title":"Pediatr Transplant"},{"key":"2572_CR8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0022-3476(68)80208-2","volume":"72","author":"NC Fost","year":"1968","unstructured":"Fost NC, Esterly NB (1968) Successful treatment of juvenile hemangiomas with prednisone. J Pediatr 72:351\u2013357","journal-title":"J Pediatr"},{"key":"2572_CR9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaad.2006.05.069","volume":"56","author":"MC Garzon","year":"2007","unstructured":"Garzon MC, Huang JT, Enjolras O et al (2007) Vascular malformations: part I. J Am Acad Dermatol 56:353\u2013370","journal-title":"J Am Acad Dermatol"},{"key":"2572_CR10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/pbc.23124","volume":"57","author":"AM Hammill","year":"2011","unstructured":"Hammill AM, Wentzel MS, Gupta A et al (2011) Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer 57:1018\u20131024","journal-title":"Pediatr Blood Cancer"},{"key":"2572_CR11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bjps.2010.07.009","volume":"64","author":"WJ Holmes","year":"2011","unstructured":"Holmes WJ, Mishra A, Gorst C et al (2011) Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas. J Plast Reconstr Aesthet Surg 64:445\u2013451","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2572_CR12","unstructured":"ISSVA Classification of Vascular Anomalies \u00a9(2014) International Society for the Study of Vascular Anomalies. Available at \u201cissva.org\/classification\u201d. Accessed April 2014"},{"key":"2572_CR13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1055\/s-0032-1323823","volume":"224","author":"J Jahnel","year":"2012","unstructured":"Jahnel J, Lackner H, Reiterer F et al (2012) Kaposiform hemangioendothelioma with Kasabach. Merritt phenomenon: from vincristine to sirolimus. Klin Padiatr 224:395\u2013397","journal-title":"Klin Padiatr"},{"key":"2572_CR14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00432-013-1549-3","volume":"140","author":"L Kai","year":"2014","unstructured":"Kai L, Wang Z, Yao W et al (2014) Sirolimus, a promising treatment for refractory Kaposiform hemangioendothelioma. J Cancer Res Clin Oncol 140:471\u2013476","journal-title":"J Cancer Res Clin Oncol"},{"key":"2572_CR15","doi-asserted-by":"crossref","unstructured":"Kim D, Benjamin L, Wysong A et al (2015) Treatment of complex periorbital venolymphatic malformation in a neonate with a combination therapy of sirolimus and prednisolone. Dermatol Ther Mar 5 (Epub ahead of print)","DOI":"10.1111\/dth.12208"},{"key":"2572_CR16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00171200","volume":"10","author":"H Lackner","year":"1995","unstructured":"Lackner H, Urban C, Schwinger W et al (1995) Cyclophosphamide therapy in life-threatening inoperable cystic hygromas. Pediatr Surg Int 10:199\u2013201","journal-title":"Pediatr Surg Int"},{"key":"2572_CR17","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","volume":"358","author":"C Leaute-Labreze","year":"2008","unstructured":"Leaute-Labreze C, Dumas de la Roque E, Hubiche T et al (2008) Propranolol for severe hemangiomas of infancy. N Engl J Med 358:2649\u20132651","journal-title":"N Engl J Med"},{"key":"2572_CR18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-0034-1376264","volume":"28","author":"JF Margolin","year":"2014","unstructured":"Margolin JF, Soni HM, Pimpalwar S (2014) Medical therapy for pediatric vascular anomalies. Semin Plast Surg 28:79\u201386","journal-title":"Semin Plast Surg"},{"key":"2572_CR19","author":"WK Pan","year":"2015","unstructured":"Pan WK, Li P, Huang Q (2015) Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K\/Akt\/eNOS\/VEGF pathway. Pediatr Blood Cancer. doi: 10.1002\/pbc.25453","journal-title":"Pediatr Blood Cancer"},{"key":"2572_CR20","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/lary.21927","volume":"121","author":"J Reinglas","year":"2011","unstructured":"Reinglas J, Ramphal R, Bromwich M (2011) The successful management of diffuse lymphangiomatosis using sirolimus: a case report. Laryngoscope 121:1851\u20131854","journal-title":"Laryngoscope"},{"key":"2572_CR21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-3476(96)70446-8","volume":"128","author":"N Sadan","year":"1996","unstructured":"Sadan N, Wolach B (1996) Treatment of hemangiomas of infants with high doses of prednisone. J Pediatr 128:141\u2013146","journal-title":"J Pediatr"},{"key":"2572_CR22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1542\/peds.2008-3458","volume":"124","author":"V Sans","year":"2009","unstructured":"Sans V, de la Roque ED, Berge J et al (2009) Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 124:423\u2013431","journal-title":"Pediatrics"},{"key":"2572_CR23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-0034-1372587","volume":"226","author":"U Schroeder","year":"2014","unstructured":"Schroeder U, Lauten M, Stichtenoth G et al (2014) Laryngomalacia and complicated, life-threatening mTOR-positive Kaposiform hemangioendothelioma cured by Supraglottoplasty and sirolimus. Klin Padiatr 226:362\u2013368","journal-title":"Klin Padiatr"},{"key":"2572_CR24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/pbc.20461","volume":"48","author":"C Timke","year":"2007","unstructured":"Timke C, Krause MF, Oppermann HC et al (2007) Interferon alpha 2b treatment in an eleven-year-old boy with disseminated lymphangiomatosis. Pediatr Blood Cancer 48:108\u2013111","journal-title":"Pediatr Blood Cancer"},{"key":"2572_CR25","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/pbc.23178","volume":"57","author":"CC Trenor","year":"2011","unstructured":"Trenor CC (2011) Sirolimus for refractory vascular anomalies. Pediatr Blood Cancer 57:904\u2013905","journal-title":"Pediatr Blood Cancer"},{"key":"2572_CR26","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/pbc.25241","volume":"62","author":"T Uno","year":"2015","unstructured":"Uno T, Ito S, Nakazawa A et al (2015) Successful treatment of Kaposiform hemangioendothelioma with everolimus. Pediatr Blood Cancer 62:536\u2013538","journal-title":"Pediatr Blood Cancer"},{"key":"2572_CR27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1651-2227.1988.tb10718.x","volume":"77","author":"T Vesikari","year":"1988","unstructured":"Vesikari T, Nuutila A, Cantell K (1988) Neurologic sequelae following interferon therapy of juvenile laryngeal papilloma. Acta Paediatr Scand 77:619\u2013622","journal-title":"Acta Paediatr Scand"},{"key":"2572_CR28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MPH.0000000000000068","volume":"37","author":"Z Wang","year":"2013","unstructured":"Wang Z, Li K, Dong K et al (2013) Successful treatment of Kasabach-Merritt phenomenon arising from Kaposiform hemangioendothelioma by sirolimus. J Pediatr Hematol Oncol 37:72\u201373","journal-title":"J Pediatr Hematol Oncol"},{"key":"2572_CR29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-3476(05)81844-X","volume":"118","author":"CW White","year":"1991","unstructured":"White CW, Wolf SJ, Korones DN et al (1991) Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a. J Pediatr 118:59\u201366","journal-title":"J Pediatr"},{"key":"2572_CR30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00006534-196701000-00010","volume":"39","author":"HA Zarem","year":"1967","unstructured":"Zarem HA, Edgerton MT (1967) Induced resolution of cavernous hemangiomas following prednisolone therapy. Plast Reconstr Surg 39:76\u201383","journal-title":"Plast Reconstr Surg"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-015-2572-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-015-2572-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-015-2572-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:42:19Z","timestamp":1599093739000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-015-2572-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,4]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["2572"],"URL":"https:\/\/doi.org\/10.1007\/s00431-015-2572-y","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,4]]}}}